巴诺减少肠道酸盐吸收的机制:一个假设
Takeshi Nakanishi1,2, Tilman B Drueke3, Takahiro Kuragano1
1Division of Kidney, Dialysis and Cardiology, Department of Internal Medicine, Hyogo Medical University, Nishinomiya, Hyogo, Japan.
Clinical kidney journal
|January 7, 2026
概括
/交换器异形3 (NHE3) 抑制剂Tenapanor通过增加结肠的pH值来降低血清酸盐,从而改变酸盐的吸收. 这种机制可能涉及肠道内的静电相互作用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 特纳帕诺是一种选择性/交换器异型3 (NHE3) 抑制剂,最初是针对便秘的刺激性肠综合征开发的.
- 临床前和临床研究表明,天帕诺降低了胃肠道酸盐的吸收,有助于透析患者控制血清酸盐.
- 确切的NHE3抑制机制,酸盐处理效应和主要作用部位尚不清楚.
研究的目的:
- 通过增强的结肠二碳酸盐分泌,探讨tenapanor诱导的NHE3抑制会通过增强的结肠二碳酸盐分泌提高光线pH值的假设.
- 为了研究改变的光线pH值如何影响酸盐的分化和吸收.
- 提出一种机制,涉及到细胞通路的静电性质,在tenapanor的酸盐降低效应.
主要方法:
- 对tenapanor的作用机制进行现有临床前和临床研究的审查.
- 在不同的pH条件下对酸盐物种化的分析.
- 假设静电相互作用在半细胞酸盐运输中的作用.
主要成果:
- 松醇诱导的NHE3抑制可以通过增强结肠中的二碳酸盐分泌来增加光线pH值.
- 升高的光pH值会改变酸盐的物种化,可能有利于更难吸收的形式.
- 最近的证据表明,单价酸盐物种被更有效地吸收,并且在更高的pH值时,细胞透性下降.
结论:
- 帕诺的酸盐降低作用可能源于结肠的pH值升高和酸盐特异性的改变.
- 紧密结合的细胞孔内的负电静电环境可能会选择性地阻碍双价酸盐的运输.
- 需要进一步的研究来证实对细胞通路静电性质对特纳帕诺尔疗效的贡献.
相关概念视频
Hormones and Bone Tissue
3.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.7K
Drug Elimination by Renal Route: Tubular Reabsorption
4.8K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
4.8K
Renal Drug Excretion: Tubular Secretion
763
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
763
Drug Elimination by Renal Route: Tubular Secretion
3.2K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
3.2K
Carrier-Mediated Transport
1.1K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.1K
Drug Absorption Mechanism: Passive Membrane Transport
6.5K
Passive transport is a method of drug absorption where small, lipid-soluble drugs can move across the cell membrane. This movement happens along the concentration gradient, which is a natural flow from higher to lower concentration areas. The speed at which the drug moves is directly related to its lipid–water partition coefficient. This means that the more a drug dissolves in lipids, the faster it diffuses or spreads throughout the body. It is important to note that most drugs are either...
6.5K


